Hong Kong (HSI) Healthcare Services Industry Analysis

Industry Valuation and Performance

Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sat, 13 Aug 2022	HK$71.2b	HK$16.3b	-HK$5,610,937,716.00	26.9x	-12.7x	4.4x
Mon, 11 Jul 2022	HK$74.7b	HK$16.0b	-HK$5,751,400,119.00	34.4x	-13x	4.7x
Wed, 08 Jun 2022	HK$51.4b	HK$13.9b	-HK$5,012,154,021.00	26.1x	-10.3x	3.7x
Fri, 06 May 2022	HK$40.6b	HK$11.7b	-HK$5,513,112,217.00	36.8x	-7.4x	3.5x
Sun, 03 Apr 2022	HK$62.5b	HK$24.9b	-HK$3,449,672,221.00	37.4x	-18.1x	2.5x
Tue, 01 Mar 2022	HK$93.3b	HK$30.7b	-HK$3,673,981,573.00	23.9x	-25.4x	3x
Thu, 27 Jan 2022	HK$89.4b	HK$30.2b	-HK$3,775,817,188.00	28.1x	-23.7x	3x
Sat, 25 Dec 2021	HK$97.8b	HK$30.1b	-HK$3,758,060,110.00	28.9x	-26x	3.3x
Mon, 22 Nov 2021	HK$118.1b	HK$30.0b	-HK$3,740,170,360.00	30.6x	-31.6x	3.9x
Wed, 20 Oct 2021	HK$143.9b	HK$30.2b	-HK$3,638,595,947.00	31.7x	-39.6x	4.8x
Fri, 17 Sep 2021	HK$144.7b	HK$30.0b	-HK$3,837,550,044.00	33.8x	-37.7x	4.8x
Sun, 15 Aug 2021	HK$181.1b	HK$29.8b	-HK$3,817,522,240.81	36.5x	-47.4x	6.1x
Thu, 10 Jun 2021	HK$228.7b	HK$27.4b	-HK$2,429,970,754.31	34.9x	-94.1x	8.3x
Wed, 03 Mar 2021	HK$201.3b	HK$24.3b	HK$142.2m	47.6x	1416.2x	8.3x
Sat, 05 Dec 2020	HK$167.4b	HK$21.6b	HK$200.6m	29.6x	834.2x	7.7x
Tue, 08 Sep 2020	HK$178.8b	HK$20.2b	HK$85.0m	68.1x	2103.9x	8.9x
Mon, 01 Jun 2020	HK$161.7b	HK$19.6b	HK$535.5m	60.6x	302.1x	8.2x
Thu, 05 Mar 2020	HK$134.5b	HK$19.4b	HK$1.0b	52.1x	133.4x	6.9x
Sun, 08 Dec 2019	HK$114.9b	HK$17.6b	HK$1.1b	34.5x	105.5x	6.5x
Sat, 31 Aug 2019	HK$100.2b	HK$16.3b	HK$1.2b	20.9x	86.8x	6.1x

Current Industry PE

Investors are pessimistic on the Hong Kong Healthcare Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The 3-year average PS ratio of 6.3x is higher than the industry's current PS ratio of 4.4x.

Past Earnings Growth

Total earnings for the Healthcare Services industry have declined over the last three years, with the industry now making a loss overall.
Meanwhile revenues have remained mostly flat.
This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Hong Kong Healthcare Services compare with similar industries?


HK Market	0.30%
Healthcare	-1.84%
Healthcare Services	-1.85%
Healthcare Services	-1.33%
Healthcare Distributors	-1.67%
Healthcare Facilities	-2.41%
Managed Healthcare	-11.43%

Industry PEThere is insufficient data on the sub-industries of this industry.

Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
2325 Yunkang Group	HK$18.74	3.0% +HK$335.5m	n/a	PE26.9x
286 Aidigong Maternal & Child Health	HK$0.47	10.6% +HK$194.2m	-63.3%	PE385.2x
1406 Clarity Medical Group Holding	HK$1.30	13.0% +HK$78.2m	n/a	PE50.2x
3886 Town Health International Medical Group	HK$0.48	2.1% +HK$73.8m	-26.5%	PE162.8x
8037 China Biotech Services Holdings	HK$1.20	5.3% +HK$57.8m	-23.6%	PE22x

Company

Last Price

Valuation

2325 Yunkang Group

HK$18.74

3.0%
+HK$335.5m

n/a

PE26.9x

286 Aidigong Maternal & Child Health

HK$0.47

10.6%
+HK$194.2m

-63.3%

PE385.2x

1406 Clarity Medical Group Holding

HK$1.30

13.0%
+HK$78.2m

n/a

PE50.2x

3886 Town Health International Medical Group

HK$0.48

2.1%
+HK$73.8m

-26.5%

PE162.8x

8037 China Biotech Services Holdings

HK$1.20

5.3%
+HK$57.8m

-23.6%

PE22x

RMH Holdings Limited Appoints He Weiqing as Chief Executive Officer

The board of directors of RMH Holdings Limited announced that He Weiqing, who is currently an executive Director, interim chief executive officer of the Company and a member of the remuneration committee of the Company, has been appointed as the CEO with effect from 5 August 2022. He Weiqing, aged 57, graduated from the Atmospheric Science Department of the Sun Yat-sen University in Guangzhou with a Bachelor of Science Degree in 1986 and graduated from the Management School of the same university with a Master's Degree in Economics in 1989. He was appointed as an executive Director on 10 January 2022. He has long been engaged in corporate management, financial management and project investment and management. He had held senior positions at the headquarters and branches of a number of renowned companies in the People's Republic of China, and acted as the project manager of various asset management companies and private equity investment companies in Shenzhen. From September 2015 to November 2017, He held senior management positions at Long Success International (Holdings) Limited, and subsequently from December 2017 to July 2020, he acted as an executive director of Grand Peace Group Holdings Limited, both of which were delisted on 19 October 2016 and 27 August 2021, respectively, pursuant to Rule 9.14 of the Rules Governing the Listing of Securities on GEM of the Stock Exchange. He has entered into a service agreement with the Company for an initial term of 3 years, unless terminated by either party in accordance with the terms thereof and subject to re-election in accordance with the articles of association of the Company.

Hong Kong (HSI) Healthcare Services Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

2159

Mediwelcome Healthcare Management & Technology (HKG:2159) Might Be Having Difficulty Using Its Capital Effectively

1406

Investor sentiment improved over the past week

6606

New Horizon Health Limited to Report First Half, 2022 Results on Aug 19, 2022

8437

RMH Holdings Limited Appoints He Weiqing as Chief Executive Officer

286

Aidigong Maternal & Child Health Limited Announces Resignation of Wong Kin Man as a Non-Executive Director

2273

Gushengtang Holdings Limited to Report First Half, 2022 Results on Aug 16, 2022

8037

China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2022

928

Less than half of directors are independent

6639

Full year 2022 earnings: EPS and revenues miss analyst expectations

1846

Founder recently bought HK$600k worth of stock

3886

Town Health International Medical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

9960

Kindstar Globalgene Technology, Inc. Provides Earnings Guidance for the Half Year Ended 30 June 2022

2325

Yunkang Group Limited Provides Earnings Guidance for the Six Months Ended June 30, 2022

2361

Sinohealth Holdings Limited has completed an IPO in the amount of HKD 402 million.

1951

Jinxin Fertility Group Limited Declares Final Dividend for the Year Ended December 31, 2021

2293

First half 2022 earnings released: EPS: HK$0.084 (vs HK$0.049 in 1H 2021)